Renal function in patients with β-thalassaemia major: A long-term follow-up study

Nephrology Dialysis Transplantation

Volumn 27, Issue 9, 2012, Pages 3547-3551

  Lai, Maria Eliana ^a,b   Spiga, Alessandra ^b   Vacquer, Stefania ^b   Carta, Maria Paola ^b   Corrias, Claudia ^b   Ponticelli, Claudio ^c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Osp Regionale per le Microcitemie   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

anaemia and renal function; iron and renal function; thalassaemia and renal function; thalassaemia major

Indexed keywords

CALCIUM; CREATININE; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CHELATION THERAPY; CREATININE BLOOD LEVEL; DRUG DOSE INCREASE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERURICOSURIA; KIDNEY FUNCTION; KIDNEY INJURY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PHOSPHATURIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THALASSEMIA MAJOR;

ADULT; BETA-THALASSEMIA; CALCIUM; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPOPHOSPHATEMIA, FAMILIAL; MALE; MIDDLE AGED; PROGNOSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; URIC ACID; YOUNG ADULT;

EID: 84865737990     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs169     Document Type: Article

References (28)

1. Sumboonnanonda A, Malasit P, Tanphaichitr VS et al. Renal tubular function in beta-thalassaemia. Pediatr Nephrol 1998; 12: 280-283.
2. Ong-ajyooth L, Malasit P, Ong-ajyooth S et al. Renal function in adult beta-thalassaemia/Hb E disease. Nephron 1998; 78: 156-161.
3. Aldudak B, Karabay Bayazit A, Noyan A et al. Renal function in pediatric patients with beta-thalassaemia major. Pediatr Nephrol 2000; 15: 109-112.
4. Koliakos G, Papachristou F, Koussi A et al. Urine biochemical markers of early renal dysfunction are associated with iron overload in beta-thalassaemia. Clin Lab Haematol 2003; 25: 105-109.
5. Smolkin V, Halevy R, Levin C et al. Renal function in children with beta-thalassaemia major and thalassaemia intermedia. Pediatr Nephrol 2008; 23: 1847-1851.
6. Economou M, Printza N, Teli A et al. Renal dysfunction in patients with beta-thalassaemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox. Acta Haematol 2010; 123: 148-152.
7. Ponticelli C, Musallam KM, Cianciulli P et al. Renal complications in transfusion-dependent beta thalassaemia. Blood Rev 2010; 24: 239-244.
8. Mastrangelo F, Lopez T, Rizzelli S et al. Function of the kidney in adult patients with Cooley's disease. A preliminary report. Nephron. 1975; 14: 229-236.
9. Koren G, Kochavi-Atiya Y, Bentur Y et al. The effects of subcutaneous deferoxamine administration on renal function in thalassaemia major. Int J Hematol 1991; 54: 371-375.
10. Bruck E. Renal function in anaemia. AMA Am J Dis Child 1953; 86: 511-512.
11. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
12. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 392(Suppl 1): S1-266.
13. Laine G, Goulle JP, Houlbreque P et al. Clearance de la creatinine. Valeurs de reference en fonction de l'age et du sex. Nouv Presse Med 1977; 30: 2690-2691.
14. Kampmann J, Sierbaek-Nielsen K, Kristensen M et al. Rapid evaluation of creatinine clearance. Acta Med Scand 1974; 196: 517-520.
15. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with the age. J Am Geriatr Soc 1985; 33: 278-285.
16. Landing BH, Gonick HC, Nadorra RL et al. Renal lesions and clinical findings in thalassaemia major and other chronic anaemias with hemosiderosis. Pediatr Pathol 1989; 9: 479-500.
17. Michelakakis H, Dimitriou E, Georgakis H et al. Iron overload and urinary lysosomal enzyme levels in beta-thalassaemia major. Eur J Pediatr 1997; 156: 602-604.
18. Sadeghi-Bojd S, Hashemi M, Karimi M. Renal tubular function in patients with beta-thalassaemia major in Zahedan, southeast Iran. Singapore Med J 2008; 49: 410-412.
19. Jalali A, Khalilian H, Ahmadzadeh A et al. Renal function in transfusion-dependent pediatric beta-thalassemia major patients. Hematology 2011; 16: 249-254.
20. Quinn CT, Johnson VL, Kim HY et al.; Thalassemia Clinical Research Network. Renal dysfunction in patients with thalassaemia. Br J Haematol 2011; 153: 111-117.
21. Fibach E, Rachmilewitz E. The role of oxidative stress in hemolytic anaemia. Curr Mol Med 2008; 8: 609-619.
22. Nagababu E, Gulyani S, Earley CJ et al. Iron-deficiency anaemia enhances red blood cell oxidative stress. Free Radic Res 2008; 42: 824-829.
23. Harris DC. Tubulointerstitial renal disease. Curr Opin Nephrol Hypertens 2001; 10: 303-313.
24. Toumba M, Sergis A, Kanaris C et al. Endocrine complications in patients with thalassaemia major. Pediatr Endocrinol Rev 2007; 5: 642-648.
25. Soliman A, Adel A, Wagdy M et al. Calcium homeostasis in 40 adolescents with beta-thalassaemia major: a case-control study of the effects of intramuscular injection of a megadose of cholecalciferol. Pediatr Endocrinol Rev 2008; 6(Suppl 1): 149-154.
26. Parakh A, Sudha S, Dubey AP et al. Celiac disease in a child with beta-thalassaemia major: a need for improved screening and awareness. J Pediatr Hematol Oncol 2008; 30: 913-914.
27. Yusuf B, McPhedran P, Brewster UC. Hypocalcemia in a dialysis patient treated with deferasirox for iron overload. Am J Kidney Dis 2008; 52: 587-590.
28. De Sanctis V, Fiscina B, Ciccone S. Severe hypercalcemia in a patient treated for hypoparathyroidism with calcitriol. Pediatr Endocrinol Rev 2010; 7: 363-365.